SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech & Pharma.T.A, -- Ignore unavailable to you. Want to Upgrade?


To: Jibacoa who wrote (505)1/30/2004 4:02:56 PM
From: Jibacoa  Read Replies (1) | Respond to of 3722
 
BIV Is up more than 17% on volume of 866K (more than 10x its daily average)

It is apparently still responding to the news this week that it has appointed Covance to manage and run its European PII study on clofarabine in patients with AML.

The stock is now trading above its October H of 5.40 and making a new 52wks H.

bigcharts.marketwatch.com

Bernard